Abstract 9538: Population-Level Impact of Systematic Urine Albumin-to-Creatinine Ratio Screening on Incident Heart Failure Cases, Hospitalizations, and Cardiovascular Mortality in High-Risk United States Adults: A Modeling Study
Abstract 9538: Bevölkerungsbezogene Auswirkung eines systematischen Screenings des Urin-Albumin-Kreatinin-Verhältnisses auf neue Herzinsuffizienzfälle, Hospitalisierungen und kardiovaskuläre Mortalität bei Hochrisiko-Erwachsenen in den USA: eine Modellierungsstudie
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.9538 ↗Auf einen Blick
Die Modellierung zeigte: Ein höheres jährliches uACR-Screening war mit weniger neuen Herzinsuffizienzfällen, weniger Hospitalisierungen und weniger kardiovaskulären Todesfällen verbunden. Der Nutzen stieg mit der Screening-Intensität.
Fragestellung
Wie wirken sich ein jährliches uACR-Screening mit höherer gegenüber aktueller Teilnahme auf Herzinsuffizienzereignisse und Mortalität bei Hochrisiko-Erwachsenen in den USA aus?
Methode
Hybrid aus Entscheidungsbaum und Markov-Modell für US-Erwachsene ≥65 Jahre mit T2D, HTN und eCVD; Vergleich von 25 % vs. 80 % uACR-Uptake, zusätzlich 100 % Uptake.
Ergebnisse
Bei 7.647.490 Berechtigten verhinderte 80 % statt 25 % Uptake 17.071 neue HF-Fälle, 23.649 HHFs und 20.498 CV-Todesfälle; 205.002 zusätzliche Lebensjahre. NNS: 246, 178, 205.
Einschränkungen
Robust in Sensitivitätsanalysen; am stärksten beeinflusst durch GDMT-Nutzung und -Wirksamkeit sowie Albuminurie-Inzidenz.
Schlussfolgerung der Autor:innen
Die Implementierung eines systematischen jährlichen uACR-Screenings wurde mit früherer Risikenerkennung, GDMT-Intensivierung, weniger HF-Fällen, HHFs und CV-Todesfällen sowie längerer Lebenserwartung verknüpft.
Kernaussagen
- 80 % statt 25 % Uptake: 17.071 HF-Fälle weniger
- 23.649 HHFs und 20.498 CV-Todesfälle weniger
- Nutzen nahm mit der Screening-Intensität zu
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Biykem Bozkurt und 7 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
Clinical practice guidelines recommend annual urine albumin-to-creatinine ratio (uACR) screening in persons with type 2 diabetes (T2D), hypertension (HTN), and established cardiovascular disease (eCVD). Albuminuria is a strong predictor of heart failure (HF) and cardiovascular (CV) outcomes; however, uptake of uACR screening remains suboptimal, limiting opportunities for early risk identification and treatment. We estimated the potential HF prevention and survival gains from expanded versus current uACR screening among high-risk US adults with T2D, HTN, and eCVD.
Methods
A hybrid decision tree/Markov model predicted clinical outcomes in a US population aged ≥65 years with T2D, HTN, and eCVD, comparing annual uACR screening at current (25%) versus higher (80%) uptake levels. US Census data and published comorbidity rates informed the size of the screening-eligible population. Published albuminuria incidence rates and uACR diagnostic accuracy determined patient classification. True-positive patients were assumed to receive intensified guideline-directed medical therapy (GDMT) consisting of SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal mineralocorticoid receptor antagonists, and projected to have lower HF progression and event rates versus undiagnosed patients, based on treatment effects estimated from the literature. The model then simulated rates of hospitalization for heart failure (HHF), CV and non-CV death, and progression from pre-clinical (Stage A/B) to clinical (Stage C/D) HF for both screening strategies. Number needed to screen (NNS) was calculated as additional patients screened per event prevented.
Results
Among 7,647,490 eligible adults, increasing uACR uptake from 25% to 80% prevented 17,071 additional incident HF cases, 23,649 HHFs, and 20,498 CV deaths, adding 205,002 life-years (LYs) population-wide (0.027 LYs per person) over a lifetime horizon. NNS to prevent one event was 246 for incident HF, 178 for HHF, and 205 for CV death. Complete (100%) uACR uptake was projected to prevent 23,279 HF cases, 32,249 HHFs, and 27,952 CV deaths, adding 279,548 LYs versus 25% uptake, demonstrating that clinical benefit scales proportionally with screening intensity. Results were robust to sensitivity analyses but most heavily influenced by GDMT utilization and effectiveness, and albuminuria incidence.
Conclusion
Implementation of systematic annual uACR screening was predicted to enable earlier recognition of risk and GDMT intensification, reducing incident HF cases, HHFs, and CV deaths, and increasing average life expectancy among high-risk US adults with T2D, HTN, and eCVD. These findings support uACR screening as a clinically impactful strategy for earlier identification of and intervention for elevated HF risk, with benefits proportional to screening uptake.
Zitieren
APA
Bozkurt, B., Pariti, B., Reifsnider, O., Kongnakorn, T., Walters, D., Zhong, L., Stargardter, M., & Januzzi, J. (2026). Abstract 9538: Population-Level Impact of Systematic Urine Albumin-to-Creatinine Ratio Screening on Incident Heart Failure Cases, Hospitalizations, and Cardiovascular Mortality in High-Risk United States Adults: A Modeling Study. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.9538
Vancouver
Bozkurt B, Pariti B, Reifsnider O, Kongnakorn T, Walters D, Zhong L, et al. Abstract 9538: Population-Level Impact of Systematic Urine Albumin-to-Creatinine Ratio Screening on Incident Heart Failure Cases, Hospitalizations, and Cardiovascular Mortality in High-Risk United States Adults: A Modeling Study. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.9538
BibTeX
@article{Bozkurt2026,
author = {Bozkurt, Biykem and Pariti, Bhrugu and Reifsnider, Odette and Kongnakorn, Thitima and Walters, David and Zhong, Lixian and Stargardter, Matthew and Januzzi, James},
title = {Abstract 9538: Population-Level Impact of Systematic Urine Albumin-to-Creatinine Ratio Screening on Incident Heart Failure Cases, Hospitalizations, and Cardiovascular Mortality in High-Risk United States Adults: A Modeling Study},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.9538}
}
EUVIMED